SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-019045
Filing Date
2023-11-14
Accepted
2023-11-14 16:31:05
Documents
80
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bcel-20230930x10q.htm   iXBRL 10-Q 2059538
2 EX-31.1 bcel-20230930xex31d1.htm EX-31.1 12689
3 EX-32.1 bcel-20230930xex32d1.htm EX-32.1 7611
  Complete submission text file 0001558370-23-019045.txt   8076767

Data Files

Seq Description Document Type Size
4 EX-101.SCH bcel-20230930.xsd EX-101.SCH 54820
5 EX-101.CAL bcel-20230930_cal.xml EX-101.CAL 44623
6 EX-101.DEF bcel-20230930_def.xml EX-101.DEF 271197
7 EX-101.LAB bcel-20230930_lab.xml EX-101.LAB 424242
8 EX-101.PRE bcel-20230930_pre.xml EX-101.PRE 398134
74 EXTRACTED XBRL INSTANCE DOCUMENT bcel-20230930x10q_htm.xml XML 1394075
Mailing Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070 650-595-2595
Atreca, Inc. (Filer) CIK: 0001532346 (see all company filings)

IRS No.: 273723255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38935 | Film No.: 231407022
SIC: 2834 Pharmaceutical Preparations